Annual D&A
$5.43 M
+$1.11 M+25.58%
31 December 2023
Summary:
Barinthus Biotherapeutics annual depreciation & amortization is currently $5.43 million, with the most recent change of +$1.11 million (+25.58%) on 31 December 2023. During the last 3 years, it has risen by +$5.22 million (+2510.10%). BRNS annual D&A is now at all-time high.BRNS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.48 M
+$8000.00+0.55%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly depreciation & amortization is currently $1.48 million, with the most recent change of +$8000.00 (+0.55%) on 30 September 2024. Over the past year, it has increased by +$1000.00 (+0.07%). BRNS quarterly D&A is now at all-time high.BRNS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.81 M
+$1000.00+0.02%
30 September 2024
Summary:
Barinthus Biotherapeutics TTM depreciation & amortization is currently $5.81 million, with the most recent change of +$1000.00 (+0.02%) on 30 September 2024. Over the past year, it has increased by +$636.00 thousand (+12.30%). BRNS TTM D&A is now at all-time high.BRNS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.6% | +0.1% | +12.3% |
| 3 y3 years | +2510.1% | +359.5% | +864.6% |
| 5 y5 years | - | - | - |
BRNS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2510.1% | at high | +1635.3% | at high | +1623.2% |
| 5 y | 5 years | at high | +2510.1% | at high | +2972.9% | at high | >+9999.0% |
| alltime | all time | at high | +2510.1% | at high | +2972.9% | at high | >+9999.0% |
Barinthus Biotherapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.48 M(+0.5%) | $5.81 M(+0.0%) |
| June 2024 | - | $1.47 M(+2.6%) | $5.81 M(+3.0%) |
| Mar 2024 | - | $1.43 M(-0.3%) | $5.64 M(+3.8%) |
| Dec 2023 | $5.43 M(+25.6%) | $1.44 M(-2.6%) | $5.43 M(+5.0%) |
| Sept 2023 | - | $1.47 M(+13.5%) | $5.17 M(+5.9%) |
| June 2023 | - | $1.30 M(+6.4%) | $4.88 M(+6.7%) |
| Mar 2023 | - | $1.22 M(+3.7%) | $4.58 M(+5.9%) |
| Dec 2022 | $4.32 M | $1.18 M(-0.9%) | $4.32 M(+24.7%) |
| Sept 2022 | - | $1.19 M(+19.8%) | $3.47 M(+46.7%) |
| June 2022 | - | $992.00 K(+2.7%) | $2.36 M(+60.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $966.00 K(+200.9%) | $1.48 M(+145.2%) |
| Dec 2021 | $602.00 K(+189.4%) | - | - |
| Dec 2021 | - | $321.00 K(+277.6%) | $602.00 K(+78.6%) |
| Sept 2021 | - | $85.00 K(-18.3%) | $337.00 K(+9.8%) |
| June 2021 | - | $104.00 K(+13.0%) | $307.00 K(+22.3%) |
| Mar 2021 | - | $92.00 K(+64.3%) | $251.00 K(+20.7%) |
| Dec 2020 | $208.00 K | $56.00 K(+1.8%) | $208.00 K(+36.8%) |
| Sept 2020 | - | $55.00 K(+14.6%) | $152.00 K(+56.7%) |
| June 2020 | - | $48.00 K(-2.0%) | $97.00 K(+98.0%) |
| Mar 2020 | - | $49.00 K | $49.00 K |
FAQ
- What is Barinthus Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual D&A year-on-year change?
- What is Barinthus Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly D&A year-on-year change?
- What is Barinthus Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM D&A year-on-year change?
What is Barinthus Biotherapeutics annual depreciation & amortization?
The current annual D&A of BRNS is $5.43 M
What is the all time high annual D&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual depreciation & amortization is $5.43 M
What is Barinthus Biotherapeutics annual D&A year-on-year change?
Over the past year, BRNS annual depreciation & amortization has changed by +$1.11 M (+25.58%)
What is Barinthus Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of BRNS is $1.48 M
What is the all time high quarterly D&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly depreciation & amortization is $1.48 M
What is Barinthus Biotherapeutics quarterly D&A year-on-year change?
Over the past year, BRNS quarterly depreciation & amortization has changed by +$1000.00 (+0.07%)
What is Barinthus Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of BRNS is $5.81 M
What is the all time high TTM D&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM depreciation & amortization is $5.81 M
What is Barinthus Biotherapeutics TTM D&A year-on-year change?
Over the past year, BRNS TTM depreciation & amortization has changed by +$636.00 K (+12.30%)